"Lindner Center of HOPE provides excellent, patient-centered, scientifically advanced care for individuals suffering with mental illness. A state-of-the-science mental-health center and charter member of the National Network of Depression Centers, the center provides psychiatric hospitalization and partial hospitalization for individuals 12 years and older, outpatient services for all ages, diagnostic and short-term residential services for adults and adolescents, intensive outpatient program for substance abuse and co-occurring disorders for adults and research."

During the past decade, Lindner Center of HOPE conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 12 clinical trials were completed, i.e. on average, 52.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lindner Center of HOPE" #1 sponsor was "Lindner Center of HOPE" with 14 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 5 trials sponsored, "Shire" with 3 trials sponsored, "Sunovion" with 3 trials sponsored and "Abbott Medical Devices" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lindner Center of HOPE" #1 collaborator was "University of Cincinnati" with 11 trials as a collaborator, "Lindner Center of HOPE" with 3 trials as a collaborator, "Jazz Pharmaceuticals" with 2 trials as a collaborator, "Shire" with 2 trials as a collaborator and "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Lindner Center of HOPE" are "Binge Eating Disorder" (13 trials), "Depressive Disorder, Major" (4 trials), "Major Depressive Disorder" (4 trials), "Bipolar Disorder" (3 trials) and "Depression" (2 trials). Many other conditions were trialed in "Lindner Center of HOPE" in a lesser frequency.

Most popular intervention types in "Lindner Center of HOPE" are "Drug" (36 trials), "Other" (6 trials), "Device" (5 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Rapastinel" (3 trials), "placebo" (3 trials), "Dasotraline" (2 trials) and "Lisdexamfetamine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lindner Center of HOPE" are 42 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Lindner Center of HOPE". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Lindner Center of HOPE, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Lindner Center of HOPE, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".